Venture Capital Investors

Parker Institute for Cancer Immunotherapy

Parker Institute for Cancer Immunotherapy is a VC investing group that assists its portfolio companies by accelerating their success.

Venture Investor Overview

Venture Investor
Parker Institute for Cancer Immunotherapy
Status
Active
Investor Type
Venture Capital
Activity Level
Funds Raised
Industry Focus
Biopharmaceutical

Contact Information

Contact
Sean Parker
Title
Founder
Mailing Address
1 Letterman Drive, Suite D3500
San Francisco, CA 94129
USA
Email Address

Background Information

Overview
We combined forces with the brightest minds in the field to radically change the way research is done -- to save lives faster. Our model is designed to remove barriers, encourage collaboration and turn ideas into real-world cancer treatments.
Profile
Parker Institute for Cancer Immunotherapy LinkedIn Company Profile
Social Media
Parker Institute for Cancer Immunotherapy Company Twitter Account
Company News
Parker Institute for Cancer Immunotherapy News
Facebook
Parker Institute for Cancer Immunotherapy on Facebook
YouTube
Parker Institute for Cancer Immunotherapy on YouTube
Last Transaction
9/4/2024

Transaction History

Our records indicate that Parker Institute for Cancer Immunotherapy invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
9/4/2024
$325,000,000
8/9/2023
$75,000,000
3/22/2022
$175,000,000

 


Investor Contacts

Title
Name
Email & Social
Founder
Sean Parker
  Sean Parker LinkedIn Profile  Sean Parker Twitter Account  Sean Parker News  Sean Parker on Facebook
Executive Director
Michael Polansky
  Michael Polansky LinkedIn Profile  Michael Polansky Twitter Account  Michael Polansky News  Michael Polansky on Facebook
Founding Partner
Tom van Loben Sels
  Tom van Loben Sels LinkedIn Profile  Tom van Loben Sels Twitter Account  Tom van Loben Sels News  Tom van Loben Sels on Facebook

 


Funds

No fund closings have been recorded for this company.

 


Portfolio Companies

Parker Institute for Cancer Immunotherapy has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company

 

 


 

 

Browse more venture capital investors:

Park+ | Parker Price Venture Capital

 

Share this article

 


About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary